EQS-Adhoc: Termination of the botulinum toxin project - adho

EQSAdhoc HAEMATO AG Key word Strategic Company Decision Termination of the botulinum toxin project 15Nov2023 1942 CETCEST Disclosure of an inside information acc to Article 17 MAR of the Regulation N

Related Keywords

Frankfurt , Brandenburg , Germany , Berlin , Huons Biopharma , , Executive Board , Basic Board , Open Market , Frankfurt Stock , Eqsadhoc , Haemato , Strategic , Company , Decision , Termination , Botulinum , Toxin , Project , Etcest , Disclosure , Inside , Information , Article , Regulation , Ransmitted , Service , Group , Ssuer , Olely , Yes ,